CompletedNCT03167307
Omega-3 for Depression in Children and Teens: A Placebo-Controlled Study
About this title
Read the official source — NCT03167307Medication studyAges 8–18Switzerland
Understand this study
Who was this study for?
Listed age limits: 8 years to 18 years.
- Listed locations
- Liestal and 6 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: April 28, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 257
- Sponsor
- Gregor Berger
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Switzerland
- Age range
- From 8 Years to 18 Years
- Official registry ID
- NCT03167307
- Official title
Show the full official title
OMEGA-3 FATTY ACIDS AS FIRST-LINE TREATMENT IN PAEDIATRIC DEPRESSION. A Phase III, 36-week, Multi-centre, Double-blind, Placebo-controlled Randomized Superiority Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Liestal · Zurich · Ganterschwil
4 more locations
- Littenheid
- Weinfelden
- Basel
- Sankt Gallen
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Gregor Berger.
Did this study involve medication?
Yes. The study involved medication, including Omega 3 fatty acid and Placebo oil.
Who was this study for?
Listed age limits: 8 years to 18 years.
